Antituberculosis medicines
WHO Essential Medicine EML section: Antituberculosis medicines
Label status: label not available in our sources
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
Isoniazid/rifapentine is an essential medicine on the World Health Organization's Model List, specifically listed under Antituberculosis medicines. This medication is used to treat tuberculosis, which is a bacterial infection that affects the lungs and other parts of the body. It is crucial for controlling the spread of tuberculosis and preventing its transmission to others. While a product label is not available in our sources, it is widely recognized for its effectiveness in treating tuberculosis. However, as with any medication, it should be used under the guidance of a healthcare professional to ensure it is used safely and effectively.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
Listed for: Antituberculosis medicines (WHO EML section heading).
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Isoniazid/rifapentine used for?
It is listed for: Antituberculosis medicines (WHO Model List section).
Is Isoniazid/rifapentine an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Isoniazid/rifapentine?
Not provided here. Ask a doctor or pharmacist.
What is Isoniazid/rifapentine?
Isoniazid/rifapentine is an essential medicine on the WHO Model List, listed under: Antituberculosis medicines. A product label is not available in our sources.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization